0001593968-23-000080.txt : 20230105
0001593968-23-000080.hdr.sgml : 20230105
20230105164531
ACCESSION NUMBER: 0001593968-23-000080
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230103
FILED AS OF DATE: 20230105
DATE AS OF CHANGE: 20230105
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: COUGHLIN CHRISTOPHER J
CENTRAL INDEX KEY: 0001110750
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38958
FILM NUMBER: 23512083
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Karuna Therapeutics, Inc.
CENTRAL INDEX KEY: 0001771917
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 270605902
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 99 HIGH STREET
STREET 2: 26TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02110
BUSINESS PHONE: 857-449-2244
MAIL ADDRESS:
STREET 1: 99 HIGH STREET
STREET 2: 26TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02110
4
1
primary_01.xml
PRIMARY DOCUMENT
X0306
4
2023-01-03
0001771917
Karuna Therapeutics, Inc.
KRTX
0001110750
COUGHLIN CHRISTOPHER J
C/O KARUNA THERAPEUTICS, INC.
99 HIGH STREET, 26TH FLOOR
BOSTON
MA
02110
true
false
false
false
Option (right to buy)
193.19
2023-01-03
4
A
false
321
110.41
A
2033-01-02
Common Stock
321
321
D
Option (right to buy)
193.19
2023-01-03
4
A
false
407
110.57
A
2033-01-02
Common Stock
407
407
D
Option (right to buy)
193.19
2023-01-03
4
A
false
67
111.94
A
2033-01-02
Common Stock
67
67
D
Option (right to buy)
193.19
2023-01-03
4
A
false
181
110.5
A
2033-01-02
Common Stock
181
181
D
This option was issued to the Reporting Person pursuant to the Issuer's Non-Employee Director Compensation Policy in lieu of retainer fees for board services in 2023.
This option vests as to 25% of the shares underlying the option award on each three month anniversary following the vesting commencement date of January 3, 2023.
/s/ Troy Ignelzi, Attorney-in-Fact
2023-01-05